Matthew Walker. UCL Queen Square Institute of Neurology. London, United Kingdom
09:00 h - 09:30 h
Can we avoid DRE with early interventions?
Elinor Ben-Menachem. Sahlgrenska Academym University of Gothenburg. Gothenburg, Sweden
09:30 h - 10:00 h
Optimal pharmacological treatment of DRE
Felix Rosenow. Epilepsy Center Frankfurt Rhine-Main. Center of Neurology and Neurosurgery, Goethe-University Frankfurt. Frankfurt, Germany
10:00 h - 10:30 h
Discussion
10:30 h - 11:00 h
Break
11:00 h - 12:00 h
Symposium Angelini. Time is life in epilepsy: Can we aim higher with cenobamate?
Chairman: Manuel Toledo Argany
Welcome and introduction to Time is Live in Epilepsy
Speaker: Manuel Toledo Argany. Hospital Universitario Vall d'Hebron. Barcelona, Spain
The twin traps of overtreatment and therapeutic nihilism in drug resistant epilepsy
Speaker: Bernhard Steinhoff. Neurology and Clinical Neurophysiology, University of Freiburg. Kork Epilepsy Center, Kehl-Kork, Germany
Round table: Early use vs late cenobamate use
Speaker: Vicente Villanueva. Hospital Universitario y Politécnico la Fe. Valencia, Spain Manuel Toledo Argany. Hospital Universitario Vall d'Hebron. Barcelona, Spain Pavel Klein. Mid-Atlantic Epilepsy and Sleep Center. Bethesda, USA Bernhard Steinhoff. Neurology and Clinical Neurophysiology, University of Freiburg. Kork Epilepsy Center, Kehl-Kork, Germany
Q&A
Speaker: Vicente Villanueva. Hospital Universitario y Politécnico la Fe. Valencia, Spain Pavel Klein. Mid-Atlantic Epilepsy and Sleep Center. Bethesda, USA Manuel Toledo Argany. Hospital Universitario Vall d'Hebron. Barcelona, Spain Bernhard Steinhoff. Neurology and Clinical Neurophysiology, University of Freiburg. Kork Epilepsy Center, Kehl-Kork, Germany
FUTURE ASMs AND THERAPIES
12:00 h - 12:45 h
ASMs under development
Meir Bialer. Institute for Drug Research, School of Pharmacy and David R. Bloom Centre for Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem. Jerusalem, Israel
12:45 h - 13:30 h
Future therapies
Jose M Serratosa Fernández. Hospital Universitario Fundación Jiménez Díaz. Madrid, Spain
13:30 h - 14:30 h
Lunch
IDIOPATHIC GENERALIZED AND AUTOIMMUNE EPILEPSIES
14:30 h - 15:00 h
Drug resistant IGEs: clinical characteristics
Javier Salas Puig. Hospital Universitario Vall d'Hebron. Barcelona, Spain
15:00 h - 15:30 h
Treatment of drug resistant IGEs
Christoph P Beier. Department of Neurology and Neurophysiology, Odense University Hospital & Svendborg Hospital. Odense, Denmark
15:30 h - 16:00 h
Treatment of autoimmune epilepsies
Mar Carreño. Hospital Clínic. Barcelona, Spain
16:00 h - 16:30 h
Discussion
Wednesday, 31st May
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES (DEEs)
08:30 h - 09:00 h
Clinical characteristics of the main types of DEEs
Elena Gardella. Danish Epilepsy Center and University of Southern Denmark. Dianalund, Denmark
09:00 h - 09:30 h
Treatment of Dravet disease and Lennox-Gastaut syndrome
Vicente Villanueva. Hospital Universitario y Politécnico la Fe. Valencia, Spain
09:30 h - 10:00 h
Treatment of other DEEs
Stephan Auvin. Robert Debré Hospital, Public Hospital Network of Paris. Paris, France
10:00 h - 10:30 h
Break
10:30 h - 11:30 h
Symposium UCB. Beyond seizure management in DEEs
Jose M Serratosa Fernández. Hospital Universitario Fundación Jiménez Díaz. Madrid, Spain Patricia Smeyers. Hospital Universitario y Politécnico La Fe. Valencia, Spain Vicente Villanueva. Hospital Universitario y Politécnico la Fe. Valencia, Spain
SPECIAL LECTURE
11:30 h - 12:15 h
Comorbidities, mortality, and SUDEP in DRE
Torbjörn Tomson. Department of Clinical Neuroscience, Karolinska Institutet. Stockholm, Sweden
12:15 h - 12:45 h
Comprehensive evaluation test
12:45 h - 13:00 h
Conclusions and awards
Jose M Serratosa Fernández. Hospital Universitario Fundación Jiménez Díaz. Madrid, Spain Manuel Toledo Argany. Hospital Universitario Vall d'Hebron. Barcelona, Spain
